Blackstone Inc. vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 76)

Blackstone Inc.

LeaderConsumer Finance

Enterprise

New York alternative asset manager (NYSE: BX) at $1.2T AUM; 2024 revenue $11.37B (+53%), AirTrunk A$24B Asia-Pacific data center acquisition, distributable earnings $6B competing with Apollo and KKR.

AI VisibilityBeta
Overall Score
B76
Category Rank
#16 of 290
AI Consensus
56%
Trend
stable
Per Platform
ChatGPT
75
Perplexity
81
Gemini
71

About

Blackstone Inc. is a New York City, New York-based alternative asset management company — publicly traded on the New York Stock Exchange (NYSE: BX) as an S&P 500 Financials component — managing $1.2 trillion in assets under management across private equity, real estate, credit and insurance, and hedge fund solutions through approximately 4,900 employees serving institutional investors, sovereign wealth funds, pension funds, insurance companies, and high-net-worth individuals globally. Founded in 1985 by Stephen Schwarzman and Peter G. Peterson, Blackstone grew from a boutique M&A advisory into the world's largest alternative asset manager. In fiscal year 2024, Blackstone reported revenue of $11.37 billion (+53% year-over-year) and distributable earnings of $6.0 billion (+18%), reflecting strong performance across its diversified alternative asset portfolio. AUM reached $1.2 trillion by mid-2025. CEO Steve Schwarzman and President Jonathan Gray lead the firm. Blackstone's landmark 2024 transaction was the A$24 billion acquisition of AirTrunk — Asia-Pacific's largest data center platform — through its real estate funds, positioning Blackstone as a dominant owner of AI infrastructure in the world's fastest-growing digital economy.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

76
Overall Score
90
#16
Category Rank
#9
56
AI Consensus
60
stable
Trend
stable
75
ChatGPT
99
81
Perplexity
99
71
Gemini
83
68
Claude
96
86
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.